pSivida Corp

Committee Composition

  Audit Governance and Nominating Compensation
Dr. David J. Mazzo Independent Director     Committee Chair for Compensation Committee
David Mazzo Non Executive Chairman

Dr. Mazzo is the Chief Executive Officer and a Director at Caladrius Biosciences. Prior to joining Caladrius (formerly NeoStem), Dr. Mazzo served as Chief Executive Officer and as Director of Regado Biosciences, a company focused on the development of novel anti-thrombotic drug systems for acute and sub-acute cardiovascular indications. Dr.Mazzo was also Chief Executive Officer and Director of Aeterna Zentaris, Inc. and Chief Executive Officer and Director at Chugai Pharma USA LLC,a biopharmaceutical company. Dr. Mazzo has also held senior management and executive positions in research and development and was a Director of the Essex Chimie European subsidiary at Schering-Plough Corporation. Dr.Mazzo earned a B.A. in the Honors Program (Interdisciplinary Humanities) and a B.S. in Chemistry from Villanova University. In addition, Dr.Mazzo received his M.S. in Chemistry and his Ph.D. in Analytical Chemistry from the University of Massachusetts, Amherst.

Mr. Douglas Godshall Independent Director   Member of Governance and Nominating Committee Member of Compensation Committee
Douglas Godshall Director

Doug Godshall is the Chief Executive Officer and a director of HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure. Mr. Godshall joined HeartWare in 2006 from Boston Scientific Corporation where he worked for 16 years. He held various executive and leadership positions at Boston Scientific, including President of the Vascular Surgery Division, a member of Boston Scientific's Operating Committee and had previously served as Vice President, Business Development where he oversaw more than 70 transactions including several strategic investments in the Ophthalmology arena.

Mr. Michael W. Rogers Independent Director Committee Chair for Audit Committee Member of Governance and Nominating Committee Member of Compensation Committee
Michael Rogers Director

Mr. Rogers is Chief Financial Officer of Acorda Therapeutics, Inc.,a biotechnology company focused on neurological disorders. Mr. Rogers brings significant financing, acquisition, investment banking, and partnering experience relating to pharmaceutical and biotech companies to the pSivida Board of Directors and is the Chairman of the pSivida Audit Committee. Prior to Acorda, Mr. Rogers served as Executive Vice-President and Chief Financial Officer of BG Medical Inc., a company focused on the development and commercialization of novel biomarker-based diagnostics and Executive Vice President, Chief Financial Officer and treasurer of Indevus Pharmaceuticals Inc.,a specialty pharmaceutical company, Executive Vice President and Chief Financial and Corporate Development Officer at Advanced Health Corporation, a health care information technology company,Vice President, Chief Financial Officer and Treasurer of AutoImmune, a biopharmaceutcal company, and Vice President, Investment Banking at Lehman Brothers, Inc. and at PaineWebber, Inc.

Committee Chair = Chair Committee Member = Member Independent Director = Independent Director

Search Investor Relations